Quarterly Results • Search Archive

Sai Life Sciences Limited
Results, Financials & Updates

Follow Sai Life Sciences Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Sai Life Sciences Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: SAILIFE
Revenue from operations₹554.29 CrReported in the latest covered quarter
Profit after tax₹73.29 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Sai Life Sciences Limited is an integrated Contract Research, Development, and Manufacturing Organization (CRDMO) providing end-to-end solutions to global innovator pharmaceutical and biotechnology companies. The company supports clients across the entire drug lifecycle, spanning early discovery, process research and development, clinical trials, and commercial manufacturing. The company's operations are divided between two key business pillars: Contract Research Organization (CRO) services, which encompass discovery chemistry, biology, DMPK, and preclinical evaluation; and Contract Development and Manufacturing Organization (CDMO) services, focusing on complex chemistry, scale-up, and commercial API supply.

← All quarterly results

Quarter history

Sai Life Sciences Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹554.29 Cr · PAT ₹73.29 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.